Home › Microchips Biotech, Inc. Completes Development And Clinical Demonstration Of Proprietary Drug Delivery Platform And Advances Commercialization Efforts In Diabetes, Contraception And Osteoporosis
 

Keywords :   


Microchips Biotech, Inc. Completes Development And Clinical Demonstration Of Proprietary Drug Delivery Platform And Advances Commercialization Efforts In Diabetes, Contraception And Osteoporosis

2014-12-29 01:32:30| drugdiscoveryonline Home Page

Microchips Biotech, Inc., formerly MicroCHIPS, Inc., recently announced the completion of the development and clinical demonstration of its proprietary drug delivery technology, a microchip-based implant capable of storing and releasing precise doses of a drug on-demand or at scheduled intervals for up to 16 years

Tags: and development delivery efforts

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Easing US inflation stokes interest rate cut debate
15.05Free From Skincare Award Finalists Announced
15.05Sub-postmasters are self-indulgent, said PO exec
15.05Axalta Hosting Strategy Day; Outlining Three-Year Plan for Accelerating Performance
15.05Pork has its place in healthy, sustainable global diets
15.05BASF Paves the Way for Young Painters at WorldSkills Finals Lyon 2024
15.05Orchard Custom Beauty to Showcase New Product Concepts at PLMA World of Private Label in Amsterdam
15.05Sontara Offers Sri Flo Wipes
More »